BlackBerry, formerly known as Research in Motion, announced today that is was “exploring a potential sale of the company or a joint venture” as part of efforts to explore strategic alternatives for its business.
Envision IP analyzed BlackBerry’s US patent portfolio in 2012, when the company previously announced plans to explore its strategic options. As of last year, we identified over 3,600 US patents assigned to BlackBerry (Research in Motion) covering wireless technologies, device hardware, operation system software, and various mobile device features and functionality.
After today’s announcement, Envision IP reviewed BlackBerry’s historical US patent application filing trends to understand how the company’s traditional R&D and patenting focus has fared in recent years, and how it may play into any strategic options BlackBerry may consider.
Since 2003, BlackBerry has shown a generally upward trend in patent filings, with a peak of 1,345 filings in 2010, and 1,344 filings in 2011. In 2012, BlackBerry filed 1,142 US patent applications, however this number could be higher as patent applications publish 18 months after filing.
BlackBerry’s pace of filings is generally comparable to its peers. BlackBerry’s 2011 US patent application filings of 1,344 topped Google’s 1,312 filings (includes Motorola Mobility), and Nokia’s 1,062 filings.
BlackBerry’s patent application filing trends show that the company has continued its focus on R&D and innovation, and it has not slowed in its patenting activity. Given the resources BlackBerry continues to devote to obtaining patents on its technology, we anticipate BlackBerry will carefully explore its IP licensing and enforcement options to generate further revenue from its patent portfolio. While a sale in-part or whole of its patent portfolio may be an option, we believe that aggressive licensing and monetization may provide for a beneficial long-term revenue model for BlackBerry.
Check out more from Envision IP here.
Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]
Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]
Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]
A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]
Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]
The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]